Sodium‐glucose co‐transporter 2 inhibitors in acute heart failure: real‐world prescription trends and outcomes analysis
Abstract Aims Sodium‐glucose co‐transporter 2 (SGLT2) inhibitors have shown potential therapeutic benefits in heart failure (HF). However, data on their real‐world usage and benefits in acute decompensated heart failure (ADHF) are limited. Methods and results We conducted a post hoc analysis of real...
Salvato in:
| Autori principali: | , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2024-02-01
|
| Serie: | ESC Heart Failure |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1002/ehf2.14597 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|